Journal of Clinical Oncology (JCO) Podcast
Episodes
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
14 May 2026
Contributed by Lukas
Guest Dr. Glenwood Goss discuss JCO article, "Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer" and the implications ...
JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
27 Apr 2026
Contributed by Lukas
Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line Therapy f...
Infections in Two Diet Strategies in HSCT and Leukemia Patients
09 Apr 2026
Contributed by Lukas
Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, "Randomized Non-inferiority Trial of a Liberalized Diet Versus the Neutropenic...
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?
30 Mar 2026
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, "Phased Variant–Supported Circulating Tumor DNA as a Pro...
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC
12 Mar 2026
Contributed by Lukas
Guest Dr. John Gore and host Dr. Davide Soldato discuss JCO article, "12-Month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladde...
Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC
23 Feb 2026
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, "Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy fo...
Ribociclib Plus Letrozole in Recurrent LGSOC: GOG 3026
23 Feb 2026
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, "Phase 2 Trial of Ribociclib plus Letrozole in Women with Recu...
NCI Working Group on Biochemically Recurrent Prostate Cancer
12 Feb 2026
Contributed by Lukas
Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, "National Cancer Institute's Working Group on Biochemica...
Association Between EOL SACT and Healthcare Utilization
08 Jan 2026
Contributed by Lukas
Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article "Association Between Systemic Anticancer Therapy Admi...
Milan Consensus Endpoints for Bladder Preservation in MIBC
11 Dec 2025
Contributed by Lukas
Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article "End Points for the Next-Generation Bladder-Sparing Periope...
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL
09 Dec 2025
Contributed by Lukas
JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to discuss simult...
JCO at 2025 ASH: A New Validated Staging System for AL Amyloidosis: AL-ISS
07 Dec 2025
Contributed by Lukas
JCO Editorial Fellow Peter Li and author Dr. Jahanzaib Khwaja discuss the ASH 25 Simultaneous Publication article, "A New Validated Staging System...
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC
24 Nov 2025
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, "Simultaneous Durvalumab an...
Health Outcomes in Older Childhood Cancer Survivors
20 Nov 2025
Contributed by Lukas
Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Repo...
Long-Term Remission After Cilta-cel in Patients With RRMM
13 Nov 2025
Contributed by Lukas
Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article "Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacab...
JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
27 Oct 2025
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in ...
Income Among Adolescents and Young Adults Surviving Cancer
09 Oct 2025
Contributed by Lukas
Host Dr. Shannon Westin and guest Dr. Giancarlo Di Guiseppe discuss the JCO article "Long-Term Dynamic Financial Impacts Among Adolescents and Young A...
JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs
29 Sep 2025
Contributed by Lukas
In this JCO Article Insights episode, Dr. Ece Cal interviews Dr. Martin Wermke, author of the JCO article, "Phase I Dose-Escalation Results for the De...
TTFields in Locally Advanced Pancreatic Adenocarcinoma
11 Sep 2025
Contributed by Lukas
Host Dr. Shannon Westin and guest Dr. Hani Babiker discuss the JCO article "Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Adva...
JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC
09 Sep 2025
Contributed by Lukas
JCO fellow Dr. Ece Cali speaks with JCO Associate Editor Dr. Thomas E. Stinchcombe to discuss the JCO article "Phase 2 Dose-Randomized Study of Sunvoz...
Racial and Ethnic Disparities Among Medicare Beneficiaries
28 Aug 2025
Contributed by Lukas
Host Davide Soldato and guest Dr. John K. Lin discuss the JCO article "Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-Fo...
JCO Article Insights: Lymph Node Dissection for Lung Cancer
25 Aug 2025
Contributed by Lukas
In this JCO Article Insights episode, Dr. Joseph Matthew interviews authors Dr. Yang Zhang and Dr. Haiquan Chen about their recently published JCO art...
JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma
28 Jul 2025
Contributed by Lukas
In this JCO Article Insights episode, Michael Hughes summarizes "International Myeloma Society and International Myeloma Working Group Consensus Recom...
JCO Article Insights: Pooled Taletrectinib Efficacy and Safety
30 Jun 2025
Contributed by Lukas
In this JCO Article Insights episode, host Peter Li summarizes "Taletrectinib in ROS1-Mutated Non–Small Cell Lung Cancer: TRUST" by Pérol et al, pu...
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC
02 Jun 2025
Contributed by Lukas
JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Thomas Stinchcombe discuss the ASCO 2025 Simultaneous Publication paper "Neoadju...
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare
31 May 2025
Contributed by Lukas
JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Val...
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC
31 May 2025
Contributed by Lukas
JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "A Phase II ...
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma
31 May 2025
Contributed by Lukas
JCO Editorial Fellow Peter Li and JCO Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper "Tumor-Treating Fields with ...
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer
31 May 2025
Contributed by Lukas
JCO Editorial Fellow Dr. Peter Li and JCO Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper "Lenvatinib Plus Pembroliz...
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome
29 May 2025
Contributed by Lukas
In this JCO Article Insights episode, host Michael Hughes summarizes "Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagno...
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases
08 May 2025
Contributed by Lukas
Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untr...
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer
28 Apr 2025
Contributed by Lukas
In this JCO Article Insights episode, host Joseph Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Pha...
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment
10 Apr 2025
Contributed by Lukas
Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article "Longitudinal Results from the Nationwide Just ASK Initiative to Promote Rou...
JCO Article Insights: Smoking Assessment
31 Mar 2025
Contributed by Lukas
In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoki...
Botensilimab Plus Balstilimab in Advanced Sarcomas
13 Mar 2025
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Breelyn Wilky, discuss the JCO article, ""Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protei...
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer
24 Feb 2025
Contributed by Lukas
In this JCO Article Insights episode, Peter Li summarizes "Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without R...
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
13 Feb 2025
Contributed by Lukas
Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on ...
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC
27 Jan 2025
Contributed by Lukas
In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, "Datopotamab Deruxtecan Versus Docetaxel for Previously Treat...
Air Pollution and Breast Cancer Incidence
09 Jan 2025
Contributed by Lukas
Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article "Air Pollution and Breast Cancer Incidence in the Multiethn...
JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing
30 Dec 2024
Contributed by Lukas
In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on "Navigating Treatment Pathways in Metastatic Hormone Receptor–...
Overcoming Barriers to Make Patient-Partnered Research a Reality
12 Dec 2024
Contributed by Lukas
Host Dr. Davide Soldato and guests Dr. Suzanne George and Liz Salmi discuss their JCO article "Overcoming Systemic Barriers to Make Patient-Partnered ...
JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma
25 Nov 2024
Contributed by Lukas
In this JCO Article Insights episode, Rohit Singh provides a summary on "First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Adva...
Quality of Treatment Selection
14 Nov 2024
Contributed by Lukas
Host Dr. Davide Soldato and Dr. Aaron Mitchell discuss the JCO article "Quality of Treatment Selection for Medicare Beneficiaries With Cancer" TRANSC...
JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy
28 Oct 2024
Contributed by Lukas
In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Proph...
Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer
16 Oct 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article "Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radi...
Combining Response and Toxicity Data to Implement Project Optimus
30 Sep 2024
Contributed by Lukas
In this JCO Article Insights episode, Subodh Selukar interviews author Dr. Robert Maki on "Combining Response and Toxicity Data to Implement Project O...
CBT-I for Cancer-Related Cognitive Impairment
12 Sep 2024
Contributed by Lukas
Host Dr. Davide Soldato and Dr. Shelia Garland discuss the JCO article "Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therap...
JCO Article Insights: Assisted Reproduction in Breast Cancer Patients
26 Aug 2024
Contributed by Lukas
In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article "Fertility...
Multi-Cancer Early Detection Testing for High-Risk Patients
08 Aug 2024
Contributed by Lukas
Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Populations:...
JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
29 Jul 2024
Contributed by Lukas
In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, "Back to the Drawing Board: Overcoming Resistance t...
Functional Disability Among US Cancer Survivors
11 Jul 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper "Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Su...
CAR T-Cell Therapy for Richter's Transformation
24 Jun 2024
Contributed by Lukas
In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Anti-CD19 Chimeric Antigen Receptor T-cell therapy for Richter's Transfo...
EAZ171: Predictors of TIPN in Black Women with Breast Cancer
03 Jun 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article "ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of T...
JCO Article Insights: Final Analysis of the Ro-CHOP Trial
27 May 2024
Contributed by Lukas
In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednison...
Methylphenidate for Fatigue in Advanced Cancer
17 May 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Patrick Stone, discuss the article, Methylphenidate Versus Placebo for Treating Fatigue in People with Advanced ...
Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz
09 May 2024
Contributed by Lukas
JCO Editor in Chief, Dr. Jonathan Friedberg interviews Dr. Pamela Kunz, Editor in Chief of the new premier open access journal, JCO Oncology Advances....
JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC
29 Apr 2024
Contributed by Lukas
In this JCO Article Insights episode, Rohit Singh provides summary on two articles published in the April 10th issue of the Journal of Clinical Oncolo...
Commonly Held Beliefs About Cancer Survivorship
11 Apr 2024
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Emily S. Tonorezos and Dr. Michael Halpern, discuss their article, "Myths and Presumptions About Cancer Survivo...
JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study
25 Mar 2024
Contributed by Lukas
In this JCO Article Insights episode, Alexandra Rojek provides a summary on two long term follow studies: "Long-Term Follow-Up of Rituximab Maintenanc...
Pembrolizumab in Patients With Advanced Cancers With HTMB
14 Mar 2024
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Herbert Duvivier and Dr. Richard Schilsky, discuss the paper "Pembrolizumab in Patients With Tumors With High T...
JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis
26 Feb 2024
Contributed by Lukas
In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on "Pathologic Exploration of the Axillary Soft Tissue Microenvir...
Omission of Radiotherapy after Breast-Conserving Surgery
22 Feb 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Reshma Jagsi, discuss the paper "Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast ...
Costs of Cancer Prevention in CDH1 Variant Carriers
08 Feb 2024
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Jeremy Davis and patient advocate Kathryn Carr, discuss the paper "Costs of Cancer Prevention: Physical and Psy...
JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials
29 Jan 2024
Contributed by Lukas
In this JCO Article Insights episode, Subodh Selukar summarized findings from the original article published in the January 2024 JCO issue: "The Impor...
Debunking Sex and Disentangling Gender From Oncology
25 Jan 2024
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Ash Alpert and Spencer Adams, discuss the paper "Debunking Sex and Disentangling Gender From Oncology" recently ...
Germline EGFR Mutations and Familial Lung Cancer
11 Jan 2024
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Judy Garber and Dr. Geoffrey Oxnard, discuss the paper "Germline EGFR Mutations and Familial Lung Cancer" recen...
JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes
04 Jan 2024
Contributed by Lukas
In this episode of JCO Article Insights, host Dr. Soldato discussed with Dr. Knikman and Dr. Cats the findings of a study that assesses the influence ...
Negative Impact of Prior Authorization on Patients with Cancer
14 Dec 2023
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Michael Anne Kyle and Dr. Nancy L. Keating, discuss the paper "Prior Authorization and Association With Delayed ...
Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer
30 Nov 2023
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Nanda Horeweg and Dr. Carien Creutzberg, discuss the paper "Molecular Classification Predicts Response to Radiot...
JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events
27 Nov 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato provides summary on two articles published in the November issues of the Journal of Clinical Onco...
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
05 Nov 2023
Contributed by Lukas
In this "Podcast Takeover," Dr. Lidia Schapira guest hosts to discuss with Dr. Shannon Westin her own JCO paper, which reports on the DUO-E Trial. Dr...
JCO Article Insights: Safety and efficacy of a Novel ADC Targeting TROP-2 in Metastatic Non-Small Cell Lung Cancer (NSCLC)
30 Oct 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato interviews Dr. Jacob Sands, medical oncologist at Dana Farber Cancer Institute (Boston, MA) and A...
Economic Evaluation of a Non-Medical Financial Assistance Program on Missed Treatment Appointments Among Adults With Cancer
28 Oct 2023
Contributed by Lukas
Dr. Shannon Westin, Dr. Stephanie Wheeler, and Dr. Caitlin Biddell discuss the paper "Economic Evaluation of a Non-Medical Financial Assistance Progra...
Disparities in End-of-Life Cancer Care
12 Oct 2023
Contributed by Lukas
Shannon Westin speaks with Holly Prigerson and Alfred Neugut about their thought-provoking editorial, "You Get (Offered) What You (Can) Pay For: Expla...
Advance Care Planning in Adolescents and Young Adults with Cancer
28 Sep 2023
Contributed by Lukas
A variety of perspectives are explored as Dr. Westin speaks with Dr. Jennifer Mack, Dr. Chun Chao, and Mallory Casperson about end-of-life care planni...
JCO Article Insights: Improving Lung Cancer Screening Using Blood-Based Biomarkers
25 Sep 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato summarized finding from the original article published in the September JCO issue: "Mortality Ben...
Impact of Smoking Cessation on Mortality From Kidney Cancer
14 Sep 2023
Contributed by Lukas
Dr. Mahdi Sheikh and Dr. David Zaridze join Dr. Shannon Westin to discuss how quitting smoking after diagnosis may impact survival in kidney cancer. T...
HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
10 Sep 2023
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Helena Yu discuss the paper "HERTHENA-Lung01, a Phase 2 Trial of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutate...
JCO Article Insights: Introducing The Childhood Cancer Data Initiative
28 Aug 2023
Contributed by Lukas
In this JCO Article Insights episode, Emily Zabor interviews Dr. Gregory H. Reaman, the Scientific Director of the Childhood Cancer Data Initiative a...
Impact of Heatwaves on the Care of Patients With Cancer
02 Aug 2023
Contributed by Lukas
Dr. Shannon Westin, Dr. Abbas M. Hassan, and Dr. Leticia Nogueira discuss the impact of heatwaves on cancer care delivery and what can be done about i...
JCO Article Insights: Immunotherapy in People Living with HIV and Cancer
21 Jul 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato interviews Dr. Naqash from University of Oklahoma. Dr. Naqash provides insight into the origina...
Racial/Ethnic Differences Discovered in Multigene Germline Testing of Early-Onset Colorectal Cancer
13 Jul 2023
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Andreana Holowatyj, discuss the paper "Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences...
JCO Article Insights: Two New Prediction Models for Risk of Venous Thromboembolism in Cancer Patients
26 Jun 2023
Contributed by Lukas
In this JCO Article Insights episode, Emily Zabor summarizes two original articles from the June 1st, 2023 Journal of Clinical Oncology issue: "A Cli...
Olanzapine for Chemotherapy-Related Anorexia
22 Jun 2023
Contributed by Lukas
Dr. Shannon Westin, Dr. Lakshmi Sandhya, and Dr. Prasanth Ganesan discuss the use of olanzapine to treat chemotherapy-related anorexia, as recently pu...
PROSPECT Trial (Alliance N1048): PROs During and After Treatment for Locally Advanced Rectal Cancer
04 Jun 2023
Contributed by Lukas
Host Dr. Shannon Westin interviews guests Dr. Ethan Basch and Dr Deborah Schrag on their JCO simultaneous publication paper at ASCO's 2023 annual meet...
JCO Article Insights: Smoking Cessation for Patients with Cancer
29 May 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato summarizes three articles from the May 20th, 2023 Journal of Clinical Oncology issue: "Smoking Ce...
JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT Trial
15 May 2023
Contributed by Lukas
In this JCO Article Insights episode, Emily Zabor interviews Dr. Gulam Manji from Columbia University Irving Medical Center. Dr. Manji provides insigh...
Peritumoral Anesthetic Infiltration Impacts Survival in Early Breast Cancer
11 May 2023
Contributed by Lukas
Dr. Shannon Westin, Dr. Rajendra Badwe, and Dr. Alastair Thompson discuss the JCO paper "Effect of Peritumoral Infiltration of Local Anesthetic Before...
Intensive Caring: Reminding Patients They Matter
27 Apr 2023
Contributed by Lukas
Dr. Shannon Westin and her guest, Dr. Harvey Max Chochinov, discuss his article "Intensive Caring: Reminding Patients They Matter." TRANSCRIPT The gu...
Barriers to Clinical Trial Participation for Transgender People
13 Apr 2023
Contributed by Lukas
What factors could be excluding transgender people from oncology clinical trials, and what can we do to make them more inclusive? Dr. Westin discusses...
JCO Article Insights: Trial Update on Development of Children After Maternal Cancer During Pregnancy
27 Mar 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato interviews Dr Frederic Amant from UZ Gasthuisberg - Katholieke University Leuven. Dr. Amant discu...
Cancer Screening During the 2nd Year of the COVID-19 Pandemic
23 Mar 2023
Contributed by Lukas
Dr. Shannon Westin and her guests, Jessica Star and Dr. Ahmedin Jemal, discuss how the COVID-19 pandemic affected cancer screening in the US in 2021. ...
Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq Trial
09 Mar 2023
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Michael Atkins, Dr. Adil Daud, and Dr. Gary Schwartz, discuss a definitive work: The DREAMseq Trial. TRANSCRIPT...
JCO Article Insights: Phase III POSEIDON Clinical Trial Results
27 Feb 2023
Contributed by Lukas
In this JCO Article Insights episode, Emily Zabor summarizes two articles from the February 20th, 2023 Journal of Clinical Oncology issue: "Durvalumab...
One-Stop-Shop Comprehensive Cancer Screening Center Focused on Asymptomatic Screening
23 Feb 2023
Contributed by Lukas
Dr. Shannon Westin, Dr. Ezra Bernstein, and Dr. Nadir Arber discuss increasing cancer prevention and early detection with a one-stop-shop comprehensiv...
Improving Transparency in Phase 1 Clinical Trials
09 Feb 2023
Contributed by Lukas
Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved ...
JCO Article Insights: Elderly Patients Receiving Chemotherapy for Early-Stage Breast Cancer
30 Jan 2023
Contributed by Lukas
In this JCO Article Insights episode, Davide Soldato summarizes two articles from the January 10th, 2023 Journal of Clinical Oncology issue: "Low-Inte...
Ensuring Employment After Cancer Diagnosis
20 Jan 2023
Contributed by Lukas
Dr. Shannon Westin discusses ways to ensure continued employment for cancer patients with her guests, Dr. Cathy Bradley, Dr. Tina Shih, and Dr. Robin ...
Intersectional Maxims for a New Era in Modern Medicine
09 Dec 2022
Contributed by Lukas
Dr. Shannon Westin and Dr. Stephanie Graff discuss a revision to the famous "Simone's Maxims" and the broader nature of intersectionality. TRANSCRIPT...
Does Medicare Advantage Lead to a Disadvantage for Patients Who Need Surgery for Cancer?
21 Nov 2022
Contributed by Lukas
Dr. Shannon Westin and Dr. Mustafa Raoof discuss the paper "Medicare Advantage: A Disadvantage for Complex Cancer Surgery Patients." TRANSCRIPT Dr. Sh...